Magellan Update April 2023

BUILDERS ON SITE AT NEW LABS. The building process for Magellan’s new laboratories at Braeside has commenced. The development will include two GMP (Good Manufacturing Practice) laboratories. The factory/office complex is already complete and construction of Magellan laboratories has commenced. The first lab to be completed will be the Research and Development laboratory which will enable Magellan […]

Magellan is pleased to announce the results of our Phase 1/2 allogeneic (donor) stem cell trial. The findings are published in Osteoarthritis and Cartilage Open the open-access journal of Osteoarthritis Research Society International (OARSI)

Australia’s Federal Health Minister announces $7 million grant to Magellan Stem Cells

NOTE: Magellan Stem Cells does not treat patients. For those seeking more information on osteoarthritis treatment, please contact our collaborative clinical research partner, Melbourne Stem Cell Centre Research

For more information please email info@magellanstemcells.com.au or call 03 9270 8080

Investment Enquiry

Download the full Investor Presentation